STL Index for: Claire Fason

Review of topical ruxolitinib as a promising JAK inhibitor for mild to moderate hidradenitis suppurativa, including early trial results, safety data, and its role in addressing unmet treatment needs.

Nanodermatology uses nanoparticles (1-1000 nanometers) to enhance transdermal drug delivery for treating psoriasis, vitiligo, acne, and atopic dermatitis. Learn about nanocarriers, liposomes, and how nanotechnology improves topical medication penetration while reducing side effects.